Skip to main content

02-07-2024 | Alzheimer's Disease | News

EAN 2024

Major changes needed in healthcare systems as antibodies against β-amyloid come onto the market Over time, various drugs have been developed to treat Alzheimer's disease that target amyloid, but not always with great success. Certain antibodies against β-amyloid do show promise. The European Medicines Agency (EMA) is assessing 2 of these drugs, but what will it mean for our healthcare system if they come onto the market?

Related topics